FDAnews
www.fdanews.com/articles/158740-delcath-ousts-ceo-amid-failed-fda-bid-for-liver-cancer-treatment-system

Delcath Ousts CEO Amid Failed FDA Bid for Liver Cancer Treatment System

September 18, 2013
Delcath lost a few more points after the company announced the termination of president & CEO Eamonn Hobbs, who will be replaced in the interim by two executives from within the company.
MassDevice